Cargando…
Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice
BACKGROUND: Despite considerable progress in the development of anticancer therapies, there is still a high mortality rate caused by cancer relapse and metastasis. Dormant or slow-cycling residual tumor cells are thought to be a source of tumor relapse and metastasis, and are therefore an obstacle t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568736/ https://www.ncbi.nlm.nih.gov/pubmed/23270473 http://dx.doi.org/10.1186/1741-7015-10-172 |
_version_ | 1782258808864636928 |
---|---|
author | Sun, Qing Zhong, Yong Wu, Fan Zhou, Chunxia Wang, Dongmei Ma, Wenbo Zhang, Youhui Zhang, Shuren |
author_facet | Sun, Qing Zhong, Yong Wu, Fan Zhou, Chunxia Wang, Dongmei Ma, Wenbo Zhang, Youhui Zhang, Shuren |
author_sort | Sun, Qing |
collection | PubMed |
description | BACKGROUND: Despite considerable progress in the development of anticancer therapies, there is still a high mortality rate caused by cancer relapse and metastasis. Dormant or slow-cycling residual tumor cells are thought to be a source of tumor relapse and metastasis, and are therefore an obstacle to therapy. In this study, we assessed the drug resistance of tumor cells in mice, and investigated whether vaccination could promote survival. METHODS: The mouse colon carcinoma cell line CT-26 was treated with 5-fluorouracil to assess its sensitivity to drug treatment. Mice with colon tumors were immunized with inactivated slow-cycling CT-26 cells to estimate the efficacy of this vaccine. RESULTS: We identified a small population of slow-cycling tumor cells in the mouse colon carcinoma CT-26 cell line, which was resistant to conventional chemotherapy. To inhibit tumor recurrence and metastasis more effectively, treatments that selectively target the slow-cycling tumor cells should be developed to complement conventional therapies. We found that drug-treated, slow-cycling tumor cells induced a more intense immune response in vitro. Moreover, vaccination with inactivated slow-cycling tumor cells caused a reduction in tumor volume and prolonged the overall survival of tumor-bearing mice. CONCLUSIONS: These findings suggest that targeting of slow-cycling tumor cells application using immunotherapy is a possible treatment to complement traditional antitumor therapy. |
format | Online Article Text |
id | pubmed-3568736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35687362013-02-12 Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice Sun, Qing Zhong, Yong Wu, Fan Zhou, Chunxia Wang, Dongmei Ma, Wenbo Zhang, Youhui Zhang, Shuren BMC Med Research Article BACKGROUND: Despite considerable progress in the development of anticancer therapies, there is still a high mortality rate caused by cancer relapse and metastasis. Dormant or slow-cycling residual tumor cells are thought to be a source of tumor relapse and metastasis, and are therefore an obstacle to therapy. In this study, we assessed the drug resistance of tumor cells in mice, and investigated whether vaccination could promote survival. METHODS: The mouse colon carcinoma cell line CT-26 was treated with 5-fluorouracil to assess its sensitivity to drug treatment. Mice with colon tumors were immunized with inactivated slow-cycling CT-26 cells to estimate the efficacy of this vaccine. RESULTS: We identified a small population of slow-cycling tumor cells in the mouse colon carcinoma CT-26 cell line, which was resistant to conventional chemotherapy. To inhibit tumor recurrence and metastasis more effectively, treatments that selectively target the slow-cycling tumor cells should be developed to complement conventional therapies. We found that drug-treated, slow-cycling tumor cells induced a more intense immune response in vitro. Moreover, vaccination with inactivated slow-cycling tumor cells caused a reduction in tumor volume and prolonged the overall survival of tumor-bearing mice. CONCLUSIONS: These findings suggest that targeting of slow-cycling tumor cells application using immunotherapy is a possible treatment to complement traditional antitumor therapy. BioMed Central 2012-12-27 /pmc/articles/PMC3568736/ /pubmed/23270473 http://dx.doi.org/10.1186/1741-7015-10-172 Text en Copyright ©2012 Sun et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Sun, Qing Zhong, Yong Wu, Fan Zhou, Chunxia Wang, Dongmei Ma, Wenbo Zhang, Youhui Zhang, Shuren Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice |
title | Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice |
title_full | Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice |
title_fullStr | Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice |
title_full_unstemmed | Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice |
title_short | Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice |
title_sort | immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568736/ https://www.ncbi.nlm.nih.gov/pubmed/23270473 http://dx.doi.org/10.1186/1741-7015-10-172 |
work_keys_str_mv | AT sunqing immunotherapyusingslowcyclingtumorcellsprolongedoverallsurvivaloftumorbearingmice AT zhongyong immunotherapyusingslowcyclingtumorcellsprolongedoverallsurvivaloftumorbearingmice AT wufan immunotherapyusingslowcyclingtumorcellsprolongedoverallsurvivaloftumorbearingmice AT zhouchunxia immunotherapyusingslowcyclingtumorcellsprolongedoverallsurvivaloftumorbearingmice AT wangdongmei immunotherapyusingslowcyclingtumorcellsprolongedoverallsurvivaloftumorbearingmice AT mawenbo immunotherapyusingslowcyclingtumorcellsprolongedoverallsurvivaloftumorbearingmice AT zhangyouhui immunotherapyusingslowcyclingtumorcellsprolongedoverallsurvivaloftumorbearingmice AT zhangshuren immunotherapyusingslowcyclingtumorcellsprolongedoverallsurvivaloftumorbearingmice |